Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Successful ABO-Incompatible Renal Transplantation:  Blood Group A1B Donor Into A2B Recipient With Anti-A1 Isoagglutinins.

Fadeyi EA, Stratta RJ, Farney AC, Pomper GJ.

Am J Clin Pathol. 2016 Aug;146(2):268-71. doi: 10.1093/ajcp/aqw101.

PMID:
27473744
2.

Single vs dual (en bloc) kidney transplants from donors ≤ 5 years of age: A single center experience.

Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.

World J Transplant. 2016 Mar 24;6(1):239-48. doi: 10.5500/wjt.v6.i1.239.

3.

Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool.

Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, El-Hennawy H, Khan M, Rogers J.

Clin Transplant. 2016 Apr;30(4):380-92. doi: 10.1111/ctr.12697. Epub 2016 Feb 15.

PMID:
26782941
4.

A Double-Blind, Double-Dummy, Flexible-Design Randomized Multicenter Trial: Early Safety of Single- Versus Divided-Dose Rabbit Anti-Thymocyte Globulin Induction in Renal Transplantation.

Stevens RB, Wrenshall LE, Miles CD, Farney AC, Jie T, Sandoz JP, Rigley TH, Osama Gaber A.

Am J Transplant. 2016 Jun;16(6):1858-67. doi: 10.1111/ajt.13659. Epub 2016 Mar 7.

PMID:
26696251
5.

Evolution of Islet Transplantation for the Last 30 Years.

Farney AC, Sutherland DE, Opara EC.

Pancreas. 2016 Jan;45(1):8-20. doi: 10.1097/MPA.0000000000000391.

PMID:
26658037
6.

The Human Pancreas as a Source of Protolerogenic Extracellular Matrix Scaffold for a New-generation Bioartificial Endocrine Pancreas.

Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G.

Ann Surg. 2016 Jul;264(1):169-79. doi: 10.1097/SLA.0000000000001364.

PMID:
26649588
7.

Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair.

Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, Murphy SV, Igel D, Mancone S, Callese T, Colucci N, Mirzazadeh M, Peloso A, Zambon JP, Farney AC, Stratta RJ, Orlando G.

Expert Rev Clin Immunol. 2016;12(2):169-82. doi: 10.1586/1744666X.2016.1112268. Epub 2015 Dec 4.

PMID:
26634874
8.

APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.

Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J.

Transplantation. 2016 Jan;100(1):194-202. doi: 10.1097/TP.0000000000000969.

PMID:
26566060
9.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor.

Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.

Case Rep Nephrol. 2015;2015:821346. doi: 10.1155/2015/821346. Epub 2015 Apr 21.

10.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.

Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW, Langefeld CD, Hicks PJ, Ma L, Freedman BI.

Kidney Int. 2015 Sep;88(3):584-92. doi: 10.1038/ki.2015.105. Epub 2015 Apr 8.

11.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL, Palanisamy A, Reeves-Daniel AM, Divers J.

Am J Transplant. 2015 Jun;15(6):1615-22. doi: 10.1111/ajt.13223. Epub 2015 Mar 24.

12.

Pancreas transplantation in C-peptide positive patients: does "type" of diabetes really matter?

Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.

J Am Coll Surg. 2015 Apr;220(4):716-27. doi: 10.1016/j.jamcollsurg.2014.12.020. Epub 2014 Dec 20.

PMID:
25667140
13.

Prospect for kidney bioengineering: shortcomings of the status quo.

Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G.

Expert Opin Biol Ther. 2015 Apr;15(4):547-58. doi: 10.1517/14712598.2015.993376. Epub 2015 Feb 1. Review.

PMID:
25640286
14.

Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients.

Farney AC, Rogers J, Orlando G, Stratta RJ.

Curr Opin Organ Transplant. 2015 Feb;20(1):103-7. doi: 10.1097/MOT.0000000000000147. Review.

PMID:
25563996
15.

Pancreas transplantation: The Wake Forest experience in the new millennium.

Rogers J, Farney AC, Orlando G, Iskandar SS, Doares W, Gautreaux MD, Kaczmorski S, Reeves-Daniel A, Palanisamy A, Stratta RJ.

World J Diabetes. 2014 Dec 15;5(6):951-61. doi: 10.4239/wjd.v5.i6.951.

16.

Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization.

Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ.

J Nephrol. 2015 Jun;28(3):379-85. doi: 10.1007/s40620-014-0145-1. Epub 2014 Sep 30.

PMID:
25266215
17.

Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era.

Al-Shraideh Y, Farooq U, Farney AC, Palanisamy A, Rogers J, Orlando G, Buckley MR, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.

Clin Transplant. 2014 Dec;28(12):1372-82. doi: 10.1111/ctr.12463. Epub 2014 Oct 16.

PMID:
25251204
18.

Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.

Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC.

Expert Opin Biol Ther. 2014 Dec;14(12):1723-30. doi: 10.1517/14712598.2014.953049. Epub 2014 Aug 25.

PMID:
25156622
19.

5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.

Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC.

Transplant Proc. 2014 Jul-Aug;46(6):1928-31. doi: 10.1016/j.transproceed.2014.05.080.

PMID:
25131073
20.

Similar results with solitary pancreas transplantation compared with simultaneous pancreas-kidney transplantation in the new millennium.

Stratta RJ, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Rogers J.

Transplant Proc. 2014 Jul-Aug;46(6):1924-7. doi: 10.1016/j.transproceed.2014.05.079.

PMID:
25131072
Items per page

Supplemental Content

Loading ...
Write to the Help Desk